DWI及ADC值在胃癌淋巴结性质判断及化疗疗效评估中的作用
本文选题:胃肿瘤 + 淋巴结 ; 参考:《放射学实践》2015年05期
【摘要】:目的:探讨扩散加权成像(DWI)及表观扩散系数(ADC)值在进展期胃癌淋巴结性质判断中的价值,进一步探讨其在化疗疗效动态监测中的应用价值。方法:44例伴有可测淋巴结的进展期胃癌患者,分别于化疗前、化疗后3、7、30和60d行MRI-DWI检查,测量化疗前和化疗后60d每个淋巴结的长径、垂直短径,以及化疗前和化疗后各时间点每个淋巴结的ADC值,化疗后60d行手术切除及淋巴结清扫,分组切除淋巴结共1258枚送病理活检,标记淋巴结组别,按照病理结果分为全阳性组(231枚,整组切除之淋巴结均有转移)和全阴性组(495枚,整组切除之淋巴结均无转移),分析比较两组间化疗前淋巴结长径、短径及ADC值差异,分析全阳性组中各疗效组化疗前后不同时间点ADC值差异并进行统计学处理。结果:化疗前全阳性组与全阴性组淋巴结长径、短径及ADC值差异均有统计学意义(P0.05)。全阳性组中部分有效组(PR组)及稳定组(SD组)化疗前、化疗后3、7、30和60dADC值均呈上升趋势,化疗前与化疗后各时间点的ADC值差异均有统计学意义(P0.05);完全有效组(CR组)可测时间点内随时间进展ADC值也呈上升趋势,化疗前与化疗后各可测时间点的ADC值差异均有统计学意义(P0.05)。结论:DWI及ADC值可初步判断胃癌患者可测淋巴结的性质,并可动态观察和早期定量监测胃癌患者转移性淋巴结的化疗疗效。
[Abstract]:Objective: to investigate the value of diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADCC) in the diagnosis of lymph node characteristics of advanced gastric cancer and to explore the value of DWI and ADCI in dynamic monitoring of chemotherapy efficacy. Methods 44 cases of advanced gastric cancer with measurable lymph nodes were examined by MRI-DWI before chemotherapy, 3 days after chemotherapy and 60 days after chemotherapy. The length and vertical short diameter of each lymph node were measured before chemotherapy and 60 days after chemotherapy. The ADC value of each lymph node before and after chemotherapy was calculated. 1258 lymph nodes were removed and dissected 60 days after chemotherapy. A total of 1258 lymph nodes were removed and labeled with pathological biopsy. According to the pathological results, 1258 lymph nodes were divided into total positive group and total positive group. There were 495 lymph nodes with metastasis in the whole group and none in the negative group. The difference of the length, short diameter and ADC value of lymph nodes before chemotherapy between the two groups was analyzed and compared. The ADC values at different time points before and after chemotherapy in all positive group were analyzed and statistically analyzed. Results: there were significant differences in lymph node length, short diameter and ADC between total positive group and total negative group before chemotherapy (P 0.05). The ADC values of partial effective group (PR group) and stable group (SD group) before and after chemotherapy showed an increasing trend at 730 and 60 days after chemotherapy. The ADC values of all time points before chemotherapy and after chemotherapy were significantly different (P < 0.05). The ADC values of each measurable time point before chemotherapy and after chemotherapy were significantly different (P 0.05). Conclusion the value of DWI and ADC can be used to determine the measurable lymph nodes in patients with gastric cancer, and the chemotherapeutic effects of metastatic lymph nodes in patients with gastric cancer can be observed dynamically and quantitatively in the early stage.
【作者单位】: 第四军医大学西京医院放射科;第四军医大学西京医院核医学科;香港大学深圳医院;第四军医大学西京医院消化病医院;
【基金】:国家自然科学基金资助项目(81220108011,81370039)
【分类号】:R735.2;R445.2
【参考文献】
相关期刊论文 前2条
1 李婷;朱凯;郭玉林;何花;张小彪;田兆荣;;3.0T MR扩散加权成像在不同分化程度胃癌中的诊断价值[J];磁共振成像;2014年03期
2 杨凤娇;郑玄中;杨晓棠;;进展期胃癌新辅助化疗疗效评价的影像学方法研究进展[J];实用医学影像杂志;2012年02期
【共引文献】
相关期刊论文 前10条
1 张雷;邵国良;;胃癌的功能磁共振成像进展[J];国际医学放射学杂志;2013年03期
2 何萍;王燕;杨晟;于舒飞;王子平;李峻岭;王彬;郝学志;王宏羽;胡兴胜;张湘茹;石远凯;;191例EGFR突变状态不明晚期肺腺癌患者EGFR-TKIs耐药后化疗的疗效分析[J];中国肺癌杂志;2013年10期
3 李海明;;动态增强MRI在卵巢肿瘤中的研究进展[J];放射学实践;2013年09期
4 蔡江河;项昌盛;李静;张守福;陈茂华;;自拟肺癌方治疗晚期非小细胞肺癌疗效观察[J];中医药临床杂志;2013年10期
5 张弘;赵涓涓;皮亚平;徐敏;李志红;张军;;乳腺癌病灶Her2、EGF表达与乳腺癌化疗疗效和预后的关系[J];重庆医学;2013年29期
6 郑蕾;林宝钗;宋正波;谢发君;洪卫;冯建国;邵岚;张沂平;;BIM基因多态性与复治晚期非小细胞肺癌EGFR-TKI治疗疗效的关系[J];中国肺癌杂志;2013年12期
7 刘旭;王燕;李淑芳;辛士珍;曹建存;;化疗对肺癌患者生活质量的影响[J];中国肺癌杂志;2013年12期
8 Xiao-Yu Yang;Feng Xie;Ran Tao;Ai-Jun Li;Meng-Chao Wu;;Treatment of liver metastases from uveal melanoma: a retrospective single-center analysis[J];Hepatobiliary & Pancreatic Diseases International;2013年06期
9 黄莎;范南峰;李惠;杨建伟;;一线联合化疗后替吉奥维持治疗晚期胃癌24例临床分析[J];福建医药杂志;2013年05期
10 曾冬香;毕延智;盛桂凤;董益忠;宋红蕾;;参一胶囊在晚期非小细胞肺癌维持治疗中的疗效观察[J];癌症进展;2013年06期
相关会议论文 前10条
1 Ming Zhao;Jian-peng Wang;Chang-chuan Pan;Wang Li;Zi-lin Huang;Liang Zhang;Wei-jun Fang;Yong Jiang;xi-shan Li;Pei-hong Wu;;CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement[A];第九届中国肿瘤微创治疗学术大会论文集[C];2013年
2 赵晓阳;曹广劭;曹会存;刘健;王玉丹;刘诗义;李天晓;王振豫;;PTCD联合碘125粒子植入治疗晚期胰腺癌合并梗阻性黄疸[A];第九届中国肿瘤微创治疗学术大会论文集[C];2013年
3 Lizhi Niu;Lihua He;Liang Zhou;Feng Mu;Binghui Wu;Haibo Li;Zhenzhong Yang;Jiansheng Zuo;Kecheng Xu;;Percutaneous Ultrasonography and Computed Tomography Guided Pancreatic Cryoablation:Feasibility and Safety Assessment Technical Developments[A];第九届中国肿瘤微创治疗学术大会论文集[C];2013年
4 丁小兵;李观华;戈华平;;新辅助化疗方案FOLFOX6对进展期胃癌的疗效观察[A];江西省第二届胃肠外科学术会议暨江西省第十二次中西医结合普通外科学术会议论文汇编[C];2012年
5 向德雨;秦章禄;;进展期胃癌新辅助化疗的研究进展[A];江西省第二届胃肠外科学术会议暨江西省第十二次中西医结合普通外科学术会议论文汇编[C];2012年
6 邵岚;洪卫;张沂平;;联合血清肿瘤标志物建立预测厄洛替尼治疗复治非小细胞肺癌生存模型[A];2013华东胸部肿瘤论坛暨第六届浙江省胸部肿瘤论坛论文集[C];2013年
7 赵同伟;卢丽琴;钦志泉;袁国荣;高亮;陈永健;孙馨;陈韵;洪朝金;杨思福;;化疗前后CEA水平变化评价晚期非小细胞肺癌患者疗效和预后的价值[A];2013华东胸部肿瘤论坛暨第六届浙江省胸部肿瘤论坛论文集[C];2013年
8 张贝贝;何春晓;宋正波;娄广媛;余新民;赵s,
本文编号:2047836
本文链接:https://www.wllwen.com/yixuelunwen/fangshe/2047836.html